Home › NDC Lookup › Ingredients › Hepatitis B Vaccine (Recombinant)
📦 NDC / package directory — not a drug information page

Hepatitis B Vaccine (Recombinant) NDCs, Package Codes, Strengths & Labelers

This page lists NDC package records for Hepatitis B Vaccine (Recombinant) products — strengths, dosage forms, package sizes, labelers, 11-digit billing NDCs, pricing data when available, and links to each individual NDC page. It’s an NDC/package & billing directory, not a clinical drug page.

Key stats

13
Package NDCs
13
Products
13
Active listings
0
Discontinued
4
Labelers
5
Strengths
1
Dosage forms
0
With NADAC pricing

By strength, form & labeler

NDC products by strength
HEPATITIS B VIRUS SUBTYPE ADW2 HBS... 4
HEPATITIS B VIRUS SUBTYPE ADW HBSA... 3
HEPATITIS B VIRUS SUBTYPE ADW HBSA... 3
HEPATITIS B VIRUS SUBTYPE ADW2 HBS... 2
HEPATITIS B VIRUS SUBTYPE ADW HBSA... 1
By dosage form
INJECTION, SUSPENSION 13
Top labelers
Merck Sharp & Dohme LLC 5
GlaxoSmithKline Biologicals SA 4
A-S Medication Solutions 2
Bamboo US BidCo LLC 2

Browse records — 13 products

Drug / product Billing NDC NADAC / unit Status
ENGERIX-B Hepatitis B Vaccine (Recombinant) 20 ug/mL INJECTION, SUSPENSION A-S · NDC 50090-1223-01 · 1 VIAL, SINGLE-DOSE in 1 POUCH (50090-1223-1) / 1 mL in 1 VIAL, SINGLE-DOSE 50090-1223-01 — On market View →
ENGERIX-B Hepatitis B Vaccine (Recombinant) 10 ug/.5mL INJECTION, SUSPENSION GlaxoSmithKline · NDC 58160-0820-52 · 10 SYRINGE in 1 CARTON (58160-820-52) / .5 mL in 1 SYRINGE (58160-820-43) 58160-0820-52 — On market View →
ENGERIX-B Hepatitis B Vaccine (Recombinant) 20 ug/mL INJECTION, SUSPENSION GlaxoSmithKline · NDC 58160-0821-11 · 10 VIAL in 1 CARTON (58160-821-11) / 1 mL in 1 VIAL (58160-821-01) 58160-0821-11 — On market View →
ENGERIX-B Hepatitis B Vaccine (Recombinant) 20 ug/mL INJECTION, SUSPENSION GlaxoSmithKline · NDC 58160-0821-11 · 10 VIAL in 1 CARTON (58160-821-11) / 1 mL in 1 VIAL (58160-821-01) 58160-0821-11 — On market View →
ENGERIX-B Hepatitis B Vaccine (Recombinant) 10 ug/.5mL INJECTION, SUSPENSION GlaxoSmithKline · NDC 58160-0820-52 · 10 SYRINGE in 1 CARTON (58160-820-52) / .5 mL in 1 SYRINGE (58160-820-43) 58160-0820-52 — On market View →
ENGERIX-B Hepatitis B Vaccine (Recombinant) 20 ug/mL INJECTION, SUSPENSION A-S · NDC 50090-1223-01 · 1 VIAL, SINGLE-DOSE in 1 POUCH (50090-1223-1) / 1 mL in 1 VIAL, SINGLE-DOSE 50090-1223-01 — On market View →
RECOMBIVAX HB Hepatitis B Vaccine (Recombinant) 5 ug/.5mL INJECTION, SUSPENSION Merck · NDC 00006-4981-00 · 10 VIAL, SINGLE-DOSE in 1 CARTON (0006-4981-00) / .5 mL in 1 VIAL, SINGLE-DOSE (0006-4981-01) 00006-4981-00 — On market View →
RECOMBIVAX HB Hepatitis B Vaccine (Recombinant) 10 ug/mL INJECTION, SUSPENSION Bamboo · NDC 83703-0086-02 · 1 mL in 1 SYRINGE (83703-086-02) 83703-0086-02 — On market View →
RECOMBIVAX HB Hepatitis B Vaccine (Recombinant) 10 ug/mL INJECTION, SUSPENSION Merck · NDC 00006-4094-02 · 10 SYRINGE in 1 CARTON (0006-4094-02) / 1 mL in 1 SYRINGE (0006-4094-01) 00006-4094-02 — On market View →
RECOMBIVAX HB Hepatitis B Vaccine (Recombinant) 5 ug/.5mL INJECTION, SUSPENSION Merck · NDC 00006-4093-02 · 10 SYRINGE in 1 CARTON (0006-4093-02) / .5 mL in 1 SYRINGE (0006-4093-01) 00006-4093-02 — On market View →
RECOMBIVAX HB Hepatitis B Vaccine (Recombinant) 10 ug/mL INJECTION, SUSPENSION Merck · NDC 00006-4995-00 · 1 VIAL, SINGLE-DOSE in 1 CARTON (0006-4995-00) / 1 mL in 1 VIAL, SINGLE-DOSE (0006-4995-01) 00006-4995-00 — On market View →
RECOMBIVAX HB Hepatitis B Vaccine (Recombinant) 5 ug/.5mL INJECTION, SUSPENSION Bamboo · NDC 83703-0085-02 · .5 mL in 1 SYRINGE (83703-085-02) 83703-0085-02 — On market View →
RECOMBIVAX HB Hepatitis B Vaccine (Recombinant) 40 ug/mL INJECTION, SUSPENSION Merck · NDC 00006-4992-00 · 1 VIAL, SINGLE-DOSE in 1 CARTON (0006-4992-00) / 1 mL in 1 VIAL, SINGLE-DOSE (0006-4992-01) 00006-4992-00 — On market View →
Where does this data come from?
NDC package records, strengths, forms and labelers come from the openFDA NDC Directory; pricing is CMS NADAC. Grouped by active-ingredient name. This is package/billing reference data, not clinical drug information.